INBX Gross Margin

The Gross Margin of Inhibrx Inc (INBX) is 7775.20%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

INBX Gross Margin - Historical Value

Date	Value
2024-12-31	7775.20%

INBX Gross Margin - Peers Comparison

Ticker	Name	Value
950200.KQ	Psomagen Inc	23.13%
ADVM	Adverum Biotechnologies Inc	7775.20%
AFMD	Affimed NV	83.70%
EVLO	Evelo Biosciences Inc	7775.20%
EPZM	Epizyme Inc	71.95%
GILD	Gilead Sciences Inc	78.26%
SGTX	Sigilon Therapeutics Inc	7775.20%
TSHA	Taysha Gene Therapies Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
ADAP	Adaptimmune Therapeutics PLC	99.96%
ARCT	Arcturus Therapeutics Holdings Inc	7775.20%
AVXL	Anavex Life Sciences Corp	7775.20%
KALV	Kalvista Pharmaceuticals Inc	7775.20%
ORIC	Oric Pharmaceuticals Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
ALGS	Aligos Therapeutics Inc	7775.20%
GTHX	G1 Therapeutics Inc	91.28%
MRNA	Moderna Inc	70.06%
TCRR	TCR2 Therapeutics Inc	7775.20%
CLNN	Clene Inc.	79.53%
CMRX	Chimerix Inc	100.00%
HARP	Harpoon Therapeutics Inc	7775.20%
IDYA	IDEAYA Biosciences Inc	7775.20%
ABBV	Abbvie Inc	69.99%
DYN	Dyne Therapeutics Inc	7775.20%
VXRT	Vaxart Inc	100.00%
BDTX	Black Diamond Therapeutics Inc	7775.20%
KDNY	Chinook Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
ARDX	Ardelyx Inc	84.85%
BTAI	BioXcel Therapeutics Inc	5.43%
REGN	Regeneron Pharmaceuticals Inc	87.01%
AMGN	Amgen Inc	61.53%
MRUS	Merus NV	7775.20%
MTEM	Molecular Templates Inc	7775.20%
PRTA	Prothena Corporation PLC	7775.20%